A post review analysis of the interaction between hs-cTnI and the subgroups atrial fibrillation (AF), CHD, rosuvastatin treatment, and BNP levels, in relation to the outcomes of MACE, CV death, all-cause death, and non-CV death, was performed (statistical analysis is presented in the supplementary material). Here, TNNI3 is linked to atrial fibrillation.